Hideko Murooka

Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N'-{4-(4-quinolyloxy)phenyl}ureas.

Toshiyuki Shimizu, N. Takahashi, Yoshiko Kobayashi, 2005, Journal of medicinal chemistry.

A novel series of 4-phenoxyquinolines: potent and highly selective inhibitors of PDGF receptor autophosphorylation

Toshiyuki Shimizu, Yoshiko Kobayashi, M. Yagi, 1997 .

Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.

D. Im, H. Nochi, Koichi Sato, 2003, Molecular pharmacology.

A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model

Yoshiko Kobayashi, M. Shibuya, T. Yoneda, 2006, Molecular Cancer Therapeutics.